Research & Program News
Memory and Aging Program Director Dr. Stephen Salloway on the growing health crisis and how all Rhode Islanders ages 40 to 85 can help.
A look inside the Memory and Aging Program at Butler Hospital and how Southern New Englanders are contributing to the mounting battle against Alzheimer’s.
Clinical Trials Aimed at Preventing Alzheimer’s to Begin at Butler Hospital’s Memory and Aging Program
The Memory and Aging Program at Butler Hospital will launch trials of two new treatments aimed at preventing Alzheimer’s in early 2020.
Study: Amyloid Plaques in Brain Linked to Greater Growth of Tau “Tangles,” Development of Alzheimer’s
The study provides new insight into how plaques lead to cognitive decline and supports use of PET imaging to predict and diagnose dementia.
Stephen Salloway, MD, Global Leader in Alzheimer’s Research, Inducted Into Rhode Island Heritage Hall of Fame
Dr. Salloway and his team at the Memory and Aging Program at Butler Hospital are global leaders in the fight against Alzheimer’s.
The results of a landmark trial conducted in part at the Memory and Aging Program at Butler Hospital show that amyloid PET brain scan imaging significantly improves both the accuracy of diagnosis and the subsequent medical management of patients with mild cognitive impairment and dementia.
Memory and Aging Program Director Dr. Stephen Salloway, a study co-author, calls the findings a “game changer” in Alzheimer’s research.
The world’s first participant in an Alzheimer’s prevention study finished his 4 1/2-year clinical trial last month. Here’s what he has to say about the experience.
Major advances in the fight against Alzheimer's disease are on the horizon thanks to increasing support for research in recent years. An inspiring example of that support was on display locally on Saturday, November 10, when hundreds of people turned out...
This new study is currently enrolling people aged 40 – 64 with normal memory or early onset cognitive impairment. The goal is to better understand how and why some people develop this rare form of Alzheimer’s disease.